Local view for "http://purl.org/linkedpolitics/eu/plenary/2006-06-13-Speech-2-082"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2006-06-13"^^xsd:date2
dcterms:Is Part Of	lp_eu:Seventh framework programme – Nuclear research and training activities (2007-2011) (debate)2
dcterms:Language	"fr"^^xsd:language2
lpv:document identification number	"en.20060613.6.2-082"2
lpv:hasSubsequent	lp_eu:2006-06-13-Speech-2-0832
lpv:speaker	lp:Véronique Mathieu Houillon2
lpv:spokenAs	substitute; AGRI (2004-07-22--2007-01-14)3 member; Delegation to the EU-Kazakhstan, EU-Kyrgyzstan and EU-Uzbekistan Parliamentary Cooperation Committees, and for relations with Tajikistan, Turkmenistan and Mongolia (2005-10-12--2009-07-13)3 unknown; Union pour un Mouvement Populaire (2004-07-20--2009-07-13)3 member; CONT (2004-07-21--2007-01-14)3 member; EPP-ED (2004-07-20--2009-07-13)3 vice-chair; Delegation for relations with the countries of Southeast Asia and the Association of Southeast Asian Nations (ASEAN) (2004-09-21--2007-03-13)3
lpv:translated text	"Medical progress, and scientific progress in general, give rise to many debates and controversies. The crisis when it comes to determining ethical bases for medical research is, indeed, partly linked to the apparently uncontrolled, and worrying, expansion in what human beings are capable of doing. The links between science and ethics directly affect human life, and we are therefore led to make some major political choices. Our long-term responsibility is huge. Cloning for research purposes deserves to be encouraged through appropriate funding of research within the Seventh Framework Programme for Research. Researchers must be able to use stem cells in the context of fundamental and applied research. Research for therapeutic purposes is, indeed, vital if chronic or degenerative diseases such as diabetes, Parkinson’s disease, Alzheimer’s and neglected diseases are to be conquered. The European research programme must, therefore, fund only rigorously controlled research for therapeutic purposes. It must in no circumstances permit either reproductive cloning or research aimed at modifying the human genetic inheritance. Where the use of human embryonic stem cells is concerned, institutions, organisations and researchers need to be licensed and to be subject to controls in accordance with the rules of the Member State concerned."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph